mTOR and Akt signaling in cancer: SGK cycles in

Alex Toker1

  • 1Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. atoker@bidmc.harvard.edu

Molecular Cell
|July 11, 2008
PubMed

Insights

mTOR promotes cell-cycle progression by activating SGK, which then phosphorylates and retains the p27 inhibitor in the cytoplasm. This study reveals a new pathway for cell cycle regulation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The mechanistic target of rapamycin (mTOR) pathway is crucial for cell growth and proliferation.
  • Cell-cycle progression is tightly regulated by various signaling pathways and inhibitors.
  • p27 is a key cell-cycle inhibitor that controls cell division.

Purpose of the Study:

  • To elucidate an alternative mechanism by which mTOR influences cell-cycle progression.
  • To identify the downstream targets of mTOR involved in regulating cell division.
  • To understand the role of SGK in mediating mTOR's effects on cell-cycle inhibitors.

Main Methods:

  • The study utilized molecular biology techniques to investigate protein interactions and phosphorylation events.
  • Experiments involved analyzing the effects of mTOR activation on SGK and p27.
  • Cellular localization studies were performed to assess p27's subcellular distribution.

Main Results:

  • mTOR was found to phosphorylate and activate serum- and glucocorticoid-induced kinase (SGK).
  • Activated SGK subsequently phosphorylates the cell-cycle inhibitor p27.
  • Phosphorylation of p27 by SGK leads to its retention in the cytoplasm, preventing its function in the nucleus.

Conclusions:

  • A novel signaling cascade involving mTOR, SGK, and p27 in cell-cycle regulation has been identified.
  • This mechanism provides an alternative route for mTOR to promote cell-cycle progression.
  • The findings offer new insights into the complex network controlling cell division and potential therapeutic targets.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...